Pharmacovigilance Translation

In the pharmaceutical industry, precision saves lives — not only in research and development, but also in how safety information is communicated. Pharmacovigilance translation plays a critical role in monitoring, reporting, and preventing adverse drug reactions across global markets. Every report, label, and clinical document must be accurately translated to protect patients and ensure regulatory compliance.

Languages Commonly Used

Our agency provides pharmacovigilance translation services in more than 40 languages, including:

• English ↔ French (Health Canada submissions, bilingual labelling, and reporting)
• English ↔ Spanish (for Latin America and Spain)
• English ↔ German, Italian, and Portuguese (for EU regulatory bodies)
• English ↔ Chinese, Japanese, and Korean (for APAC pharmacovigilance networks)
• Arabic, Russian, and Polish (for emerging markets and regional authorities)

Each language pair follows its own set of terminology standards, and all translations are performed by native-language experts specializing in pharmacology and drug safety.

Why Accuracy Matters in Pharmacovigilance?

A single mistranslated term in a pharmacovigilance report can lead to misinterpretation of a safety signal, delayed action, or regulatory non-compliance. Health authorities such as Health Canada, the European Medicines Agency (EMA), and the U.S. Food and Drug Administration (FDA) require all safety documentation to be consistent, traceable, and linguistically correct. Precision in translation protects not only patient safety but also a company’s regulatory standing and reputation.

Our Expertise in Pharmacovigilance Translation

At Mediwords Canada, we combine linguistic precision with scientific rigour. Our team includes certified translators and reviewers with backgrounds in medicine, pharmacology, and regulatory affairs. Every pharmacovigilance translation project is managed through a multi-step process that includes terminology control, scientific review, and final validation according to ISO 17100 and Good Pharmacovigilance Practice (GVP) guidelines.

We regularly support pharmaceutical companies, Contract Research Organizations (CROs), and regulatory teams with:

• Large-scale safety data translations across multilingual regions
• Adverse event case reporting for global pharmacovigilance databases (EudraVigilance, MedDRA)
• Compliance support for submissions to Health Canada, FDA, EMA, and MHRA

Every translation is handled confidentially, using secure, encrypted systems and strict access control.

Mediwords, Your Trusted Partner for Global Pharmacovigilance Communication

As the pharmaceutical industry continues to expand internationally, accurate and timely communication is more critical than ever. With a proven track record in medical and pharmacovigilance translations, Mediwords Translation Agency ensures that your safety data speaks every language of compliance — clearly, consistently, and responsibly.

FAQ – Translating Pharmacovigilance and Drug Safety Documents

What is pharmacovigilance localization?

Pharmacovigilance translation involves the accurate adaptation of drug safety and regulatory documents into another language. It includes the translation of Individual Case Safety Reports (ICSRs), Periodic Safety Update Reports (PSURs), Risk Management Plans (RMPs), and other key documents to ensure consistent communication between pharmaceutical companies, healthcare providers, and health authorities worldwide.

Why is it important to translate pharmacovigilance documents into French in Canada?

In Canada, Health Canada requires bilingual drug safety documentation — in both English and French — for all products marketed nationally. Translating pharmacovigilance materials ensures that healthcare professionals and patients across all provinces, including Quebec, can fully understand adverse event reports, labelling, and safety communications. French translation is not only a legal requirement but also an essential component of patient safety and regulatory transparency.

Which pharmacovigilance documents require translation?

The most common documents include adverse event reports, risk management plans (RMPs), development safety update reports (DSURs), safety data exchange agreements (SDEAs), product labels, and patient information leaflets (PILs). Each must be translated precisely to comply with Good Pharmacovigilance Practice (GVP) and local regulations.

Which languages are most often used in pharmacovigilance translations?

Pharmaceutical companies typically require translations between English and French, Spanish, German, Italian, Portuguese, Chinese, Japanese, Korean, Arabic, and Russian. Each target market has its own pharmacovigilance requirements and terminology conventions, which must be respected for compliance and accuracy.

Who should translate pharmacovigilance documentation?

How do you guarantee accuracy and confidentiality?